Publications by authors named "Daniel Bandari"

Claim this Profile
R
Real-world treatment preferences among health care providers in the United States in selecting disease modifying therapies for patients with multiple sclerosis: a discrete choice experiment.
Daniel Bandari, Meagan Adamson, Michelle Bowman, Amparo Gutierrez, Amod Athavale

J Med Econ· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights From the ASPIRE Study.
Alberto Esquenazi, Gerard E Francisco, Wuwei Feng, Alessio Baricich, Philippe Gallien, Daniel S Bandari

Arch Phys Med Rehabil· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Observational Results from the ASPIRE Study: OnabotulinumtoxinA Treatment for Adult Lower Limb Spasticity.
Alberto Esquenazi, Ganesh Bavikatte, Daniel S Bandari, Wolfgang H Jost, Michael C Munin

PM R· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician- and Patient-Reported Satisfaction: Long-Term Observational Results from the ASPIRE Study.
Gerard E Francisco, Wolfgang H Jost, Ganesh Bavikatte, Daniel S Bandari, Simon F T Tang

PM R· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study.
Gerard E Francisco, Daniel S Bandari, Ganesh Bavikatte, Wolfgang H Jost, Emily McCusker

Toxicon X· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis.
Guy Buckle, Daniel Bandari, Jeffrey Greenstein, Mark Gudesblatt, Bhupendra Khatri

Mult Scler J Exp Transl Clin· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult Spasticity International Registry Study: methodology and baseline patient, healthcare provider, and caregiver characteristics.
Gerard E Francisco, Daniel S Bandari, Ganesh Bavikatte, Wolfgang H Jost, Aubrey Manack Adams

J Rehabil Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poster 281 The Adult Spasticity International Registry (ASPIRE Study): Baseline Demographics and Clinical Characteristics of Patients Treated for Spasticity.
Gerard E Francisco, Daniel Bandari, Ganesh Bavikatte, Wolfgang H Jost, Aubrey Manack Adams

PM R· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
Daniel S Bandari, Debora Sternaman, Theodore Chan, Chris R Prostko, Tamar Sapir

J Manag Care Pharm· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study.
Barry Singer, Daniel Bandari, Mark Cascione, Christopher LaGanke, John Huddlestone

BMC Neurol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The "liberation procedure" for multiple sclerosis: sacrificing science at the altar of consumer demand.
Michael N Brant-Zawadzki, Daniel S Bandari, Jose J Puangco, Barry B Rubin

J Am Coll Radiol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis